The FDA Reauthorization Act (FDARA) of 2017 sailed through a final Senate vote of 94-1 despite a drawn-out cloture vote, but several amendments were added to H.R. 2430 by unanimous consent, including a right-to-try bill and a bill that would require the Department of Health and Human Services to develop a standard for "prominently displaying" information related to a patient's opioid addiction history in electronic health records. Read More
